BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri-Shirvani J, Derakhshan MH. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47:868-876. [PMID: 29430669 DOI: 10.1111/apt.14561] [Cited by in Crossref: 195] [Cited by in F6Publishing: 168] [Article Influence: 65.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahmoud A, Bakr A, Elsaid A, Wahba Y. Prevalence of Helicobacter pylori infection among children with primary nephrotic syndrome: a cross-sectional study. Afr Health Sci 2020;20:1624-31. [PMID: 34394223 DOI: 10.4314/ahs.v20i4.15] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Maroney MJ, Ciurli S. Nickel as a virulence factor in the Class I bacterial carcinogen, Helicobacter pylori. Semin Cancer Biol 2021:S1044-579X(21)00110-3. [PMID: 33865991 DOI: 10.1016/j.semcancer.2021.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zamani M, Zamani V, Derakhshan MH, Shokri-Shirvani J. The efficacy of first-line regimens for Helicobacter pylori eradication in different continents: A systematic review and network meta-analysis protocol. Medicine (Baltimore). 2018;97:e13682. [PMID: 30558078 DOI: 10.1097/md.0000000000013682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pereira-Marques J, Ferreira RM, Pinto-Ribeiro I, Figueiredo C. Helicobacter pylori Infection, the Gastric Microbiome and Gastric Cancer. Adv Exp Med Biol 2019;1149:195-210. [PMID: 31016631 DOI: 10.1007/5584_2019_366] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
5 Canzian F, Rizzato C, Obazee O, Stein A, Flores-Luna L, Camorlinga-Ponce M, Mendez-Tenorio A, Vivas J, Trujillo E, Jang H, Chen W, Kasamatsu E, Bravo MM, Torres J, Muñoz N, Kato I. Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions. Int J Cancer 2020;147:2437-45. [PMID: 32363734 DOI: 10.1002/ijc.33032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Alzoubi H, Al-Mnayyis A, Al Rfoa I, Aqel A, Abu-Lubad M, Hamdan O, Jaber K. The Use of 13C-Urea Breath Test for Non-Invasive Diagnosis of Helicobacter pylori Infection in Comparison to Endoscopy and Stool Antigen Test. Diagnostics (Basel) 2020;10:E448. [PMID: 32635179 DOI: 10.3390/diagnostics10070448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wang C, Liu J, Shi X, Ma S, Xu G, Liu T, Xu T, Huang B, Qu Y, Guo X, Qi X. Prevalence of Helicobacter pylori Infection in Military Personnel from Northeast China: A Cross-Sectional Study. Int J Gen Med 2021;14:1499-505. [PMID: 33907452 DOI: 10.2147/IJGM.S308572] [Reference Citation Analysis]
8 Curado MP, Silva DRME, Oliveira MM, Soares F, Begnami MD, Coimbra FJF, Assumpção PP, de Sant'Ana RO, Demachki S, Dias-Neto E. Disparities in Epidemiological Profile of Gastric Adenocarcinoma in Selected Cities of Brazil. Asian Pac J Cancer Prev 2019;20:2253-8. [PMID: 31450892 DOI: 10.31557/APJCP.2019.20.8.2253] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Zamani M, Derakhshan MH, Zamani V, Shokri-shirvani J. Editorial: the prevalence of Helicobacter pylori infection worldwide-knowns and unknowns. Authors' reply. Aliment Pharmacol Ther 2018;47:1331-2. [DOI: 10.1111/apt.14618] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Fang Y, Fan C, Xie H. Effect of Helicobacter pylori infection on the risk of acute coronary syndrome: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e18348. [PMID: 31852134 DOI: 10.1097/MD.0000000000018348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Mansori K, Dehghanbanadaki H, Naderpour S, Rashti R, Moghaddam AB, Moradi Y. A systematic review and meta-analysis of the prevalence of Helicobacter pylori in patients with diabetes. Diabetes Metab Syndr 2020;14:601-7. [PMID: 32417710 DOI: 10.1016/j.dsx.2020.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Leja M, Dumpis U. What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption? Dig Dis Sci 2020;65:1632-42. [PMID: 31659615 DOI: 10.1007/s10620-019-05893-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ansari S, Akada J, Matsuo Y, Shiota S, Kudo Y, Okimoto T, Murakami K, Yamaoka Y. Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping. J Gastroenterol 2019;54:1039-51. [PMID: 31049715 DOI: 10.1007/s00535-019-01584-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Duan F, Song C, Zhang J, Wang P, Ye H, Dai L, Wang K. Evaluation of the Epidemiologic Efficacy of Eradicating Helicobacter pylori on Development of Gastric Cancer. Epidemiol Rev. 2019;41:97-108. [PMID: 31497856 DOI: 10.1093/epirev/mxz006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Abdulkhakov SR, Bordin DS, Abdulkhakov RA, Safina DD, Gizdatullina AR, Gimadieva LZ, Safina GM, Ziyatdinov AI, Maturina AM, Nyssen OP, Megraud F, O'Morain C, Perez-Gisbert J. [European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan]. Ter Arkh 2020;92:52-9. [PMID: 33346462 DOI: 10.26442/00403660.2020.08.000758] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Ansari S, Yamaoka Y. Role of vacuolating cytotoxin A in Helicobacter pylori infection and its impact on gastric pathogenesis. Expert Rev Anti Infect Ther 2020;18:987-96. [PMID: 32536287 DOI: 10.1080/14787210.2020.1782739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Veliev AM, Maev IV, Andreev DN, Dicheva DT, Zaborovskii AV, Lobanova EG, Bektemirova LG. [The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease]. Ter Arkh 2019;91:28-33. [PMID: 32598751 DOI: 10.26442/00403660.2019.08.000382] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Chitapanarux T, Jesadaporn P, Chitapanarux N, Lertprasertsuke N. Chronic gastritis according to age and Helicobacter pylori in Thailand: histopathological patterns. Scand J Gastroenterol 2021;56:228-33. [PMID: 33459087 DOI: 10.1080/00365521.2020.1869820] [Reference Citation Analysis]
19 Li C, Shi Y, Suo B, Tian X, Zhou L, Song Z. PPI-amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta-analysis. Helicobacter 2021;26:e12816. [PMID: 34002433 DOI: 10.1111/hel.12816] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mantovani A, Turino T, Altomari A, Lonardo A, Zoppini G, Valenti L, Tilg H, Byrne CD, Targher G. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis. Metabolism 2019;96:56-65. [DOI: 10.1016/j.metabol.2019.04.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
21 Alcedo J, Gracia M, García-cámara P, Palacín C, Gallego S, Jimeno-ayllon C, Frago S, Aured I, Luzón L. Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy. Gastroenterología y Hepatología 2020;43:301-9. [DOI: 10.1016/j.gastrohep.2019.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
22 Ansari S, Yamaoka Y. Helicobacter pylori Virulence Factor Cytotoxin-Associated Gene A (CagA)-Mediated Gastric Pathogenicity. Int J Mol Sci. 2020;21. [PMID: 33050101 DOI: 10.3390/ijms21197430] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
23 Ghosh P, Bhakta S, Bhattacharya M, Sharma AR, Sharma G, Lee SS, Chakraborty C. A Novel Multi-Epitopic Peptide Vaccine Candidate Against Helicobacter pylori: In-Silico Identification, Design, Cloning and Validation Through Molecular Dynamics. Int J Pept Res Ther 2021;:1-18. [PMID: 33495694 DOI: 10.1007/s10989-020-10157-w] [Reference Citation Analysis]
24 Gao C, Zhang D, Zhang T, Wang J, Han S, Graham DY, Lu H. PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis. Helicobacter 2020;25. [DOI: 10.1111/hel.12692] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
25 Pereira-Marques J, Ferreira RM, Machado JC, Figueiredo C. The influence of the gastric microbiota in gastric cancer development. Best Pract Res Clin Gastroenterol 2021;50-51:101734. [PMID: 33975676 DOI: 10.1016/j.bpg.2021.101734] [Reference Citation Analysis]
26 Berlamont H, De Witte C, De Bruyckere S, Fox JG, Backert S, Smet A, Boyen F, Haesebrouck F. Differentiation of Gastric Helicobacter Species Using MALDI-TOF Mass Spectrometry. Pathogens 2021;10:366. [PMID: 33803832 DOI: 10.3390/pathogens10030366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wan Z, Song L, Hu L, Hu M, Lei X, Huang Y, Lv Y. Helicobacter pylori infection is associated with diabetes among Chinese adults. J Diabetes Investig 2020;11:199-205. [PMID: 31207188 DOI: 10.1111/jdi.13102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Chen M, Fang Y, Wu M, Chen C, Chen Y, Yu C, Kuo C, Chiu M, Hu W, Tsai M, Hsieh C, Chen H, Bair M, Liou J; for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan. Journal of Gastroenterology and Hepatology 2019;35:233-40. [DOI: 10.1111/jgh.14828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zare Javid A, Maghsoumi-Norouzabad L, Bazyar H, Aghamohammadi V, Alavinejad P. Effects of Concurrent Omega-3 and Cranberry Juice Consumption Along with Standard Antibiotic Therapy on the Eradication of Helicobacter pylori, Gastrointestinal Symptoms, Some Serum Inflammatory and Oxidative Stress Markers in Adults with Helicobacter pylori Infection: A Study Protocol for a Randomized Controlled Trial. Infect Drug Resist 2020;13:3179-85. [PMID: 32982332 DOI: 10.2147/IDR.S270057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ngan LTM, Tan MT, Hoang NVM, Thanh DT, Linh NTT, Hoa TTH, Nuong NTM, Hieu TT. Antibacterial activity of Hibiscus rosa-sinensis L. red flower against antibiotic-resistant strains of Helicobacter pylori and identification of the flower constituents. Braz J Med Biol Res 2021;54:e10889. [PMID: 34008759 DOI: 10.1590/1414-431X2020e10889] [Reference Citation Analysis]
31 Klohe K, Amuasi J, Kaducu JM, Haavardsson I, Bogatyreva E, Onarheim KH, Harrison W, Kristensen F, Prazeres da Costa C, Winkler AS. The 2017 Oslo conference report on neglected tropical diseases and emerging/re-emerging infectious diseases - focus on populations underserved. Infect Dis Poverty 2019;8:40. [PMID: 31138293 DOI: 10.1186/s40249-019-0550-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
32 Shen X, Zhang W, Peng C, Yan J, Chen P, Jiang C, Yuan Y, Chen D, Zhu W, Yao M. In vitro anti-bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection. Chin Med 2021;16:33. [PMID: 33865425 DOI: 10.1186/s13020-021-00442-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Liu M, Zhong Y, Chen J, Liu Y, Tang C, Wang X, Zhang Y, Wang P, Logan SM, Chen W, Wei B. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection. Vaccine 2020;38:3031-41. [PMID: 32139315 DOI: 10.1016/j.vaccine.2020.02.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
34 Ramadan RA, Zaki MA, Ooda SA, Abo Khalifa HM, Ragab WS. Comparison of Serum Trefoil Factor-3 to Endoscopy in Diagnosing Helicobacter Pylori Associated Gastric Ulcer. Asian Pac J Cancer Prev 2020;21:2149-53. [PMID: 32711444 DOI: 10.31557/APJCP.2020.21.7.2149] [Reference Citation Analysis]
35 Li L, Tan J, Liu L, Li J, Chen G, Chen M, Xie J, Song Q, Huang X, Xie S. Association between H. pylori infection and health Outcomes: an umbrella review of systematic reviews and meta-analyses. BMJ Open 2020;10:e031951. [PMID: 31924635 DOI: 10.1136/bmjopen-2019-031951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Jeon HL, Kim SC, Park SH, Shin JY. The risk of serious infection in rheumatoid arthritis patients receiving tocilizumab compared with tumor necrosis factor inhibitors in Korea. Semin Arthritis Rheum 2021;51:989-95. [PMID: 34403814 DOI: 10.1016/j.semarthrit.2021.07.004] [Reference Citation Analysis]
37 Tang MYL, Chung PHY, Chan HY, Tam PKH, Wong KK. Recent trends in the prevalence of Helicobacter Pylori in symptomatic children: A 12-year retrospective study in a tertiary centre. J Pediatr Surg. 2019;54:255-257. [PMID: 30497821 DOI: 10.1016/j.jpedsurg.2018.10.079] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
38 Rajilic-Stojanovic M, Figueiredo C, Smet A, Hansen R, Kupcinskas J, Rokkas T, Andersen L, Machado JC, Ianiro G, Gasbarrini A, Leja M, Gisbert JP, Hold GL. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther 2020;51:582-602. [PMID: 32056247 DOI: 10.1111/apt.15650] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 43.0] [Reference Citation Analysis]
39 Toracchio S, Caruso RA, Perconti S, Rigoli L, Betri E, Neri M, Verginelli F, Mariani-Costantini R. Evolutionarily-Related Helicobacter pylori Genotypes and Gastric Intraepithelial Neoplasia in a High-Risk Area of Northern Italy. Microorganisms 2020;8:E324. [PMID: 32110918 DOI: 10.3390/microorganisms8030324] [Reference Citation Analysis]
40 Ansari S, Yamaoka Y. Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity. Toxins (Basel). 2019;11. [PMID: 31752394 DOI: 10.3390/toxins11110677] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 18.5] [Reference Citation Analysis]
41 Maubach G, Lim MCC, Sokolova O, Backert S, Meyer TF, Naumann M. TIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-κB pathways. EMBO Rep 2021;:e52878. [PMID: 34328245 DOI: 10.15252/embr.202152878] [Reference Citation Analysis]
42 Smith S, Fowora M, Pellicano R. Infections with Helicobacter pylori and challenges encountered in Africa. World J Gastroenterol 2019; 25(25): 3183-3195 [PMID: 31333310 DOI: 10.3748/wjg.v25.i25.3183] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
43 Spósito L, Oda FB, Vieira JH, Carvalho FA, dos Santos Ramos MA, de Castro RC, Crevelin EJ, Crotti AEM, Santos AG, da Silva PB, Chorilli M, Bauab TM. In vitro and in vivo anti-Helicobacter pylori activity of Casearia sylvestris leaf derivatives. Journal of Ethnopharmacology 2019;233:1-12. [DOI: 10.1016/j.jep.2018.12.032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
44 Ji CR, Liu J, Li YY, Guo CG, Qu JY, Zhang Y, Zuo X. Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis. BMJ Open 2020;10:e037375. [PMID: 33077561 DOI: 10.1136/bmjopen-2020-037375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Doulberis M, Papaefthymiou A, Polyzos SA, Bargiotas P, Liatsos C, Srivastava DS, Zavos C, Katsinelos P, Kountouras J. Association between Active Helicobacter pylori Infection and Glaucoma: A Systematic Review and Meta-Analysis. Microorganisms 2020;8:E894. [PMID: 32545826 DOI: 10.3390/microorganisms8060894] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Ichihara A, Ojima H, Gotoh K, Matsushita O, Take S, Okada H, Watanabe A, Yokota K. Serodiagnosis and Bacterial Genome of Helicobacter pylori Infection. Toxins (Basel) 2021;13:467. [PMID: 34357939 DOI: 10.3390/toxins13070467] [Reference Citation Analysis]
47 Guiard E, Lelievre B, Rouyer M, Zerbib F, Diquet B, Mégraud F, Tison F, Bignon E, Lassalle R, Droz-Perroteau C, Moore N, Blin P. Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study. Drug Saf 2019;42:993-1003. [PMID: 31069703 DOI: 10.1007/s40264-019-00821-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
48 Jukic I, Vukovic J, Rusic D, Bozic J, Bukic J, Leskur D, Seselja Perisin A, Modun D. Adherence to Maastricht V/Florence consensus report for the management of Helicobacter pylori infection among primary care physicians and medical students in Croatia: A cross-sectional study. Helicobacter 2021;26:e12775. [PMID: 33368852 DOI: 10.1111/hel.12775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Nikaido M, Kakiuchi N, Miyamoto S, Hirano T, Takeuchi Y, Funakoshi T, Yokoyama A, Ogasawara T, Yamamoto Y, Yamada A, Setoyama T, Shimizu T, Kato Y, Uose S, Sakurai T, Minamiguchi S, Obama K, Sakai Y, Muto M, Chiba T, Ogawa S, Seno H. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer 2021;24:1102-14. [PMID: 33961152 DOI: 10.1007/s10120-021-01191-8] [Reference Citation Analysis]
50 Akeel M, Elmakki E, Shehata A, Elhafey A, Aboshouk T, Ageely H, Mahfouz MS. Prevalence and factors associated with H. pylori infection in Saudi patients with dyspepsia. Electron Physician 2018;10:7279-86. [PMID: 30258561 DOI: 10.19082/7279] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
51 Georgopoulos S, Papastergiou V. An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection. Expert Opin Pharmacother 2021;22:729-41. [PMID: 33131337 DOI: 10.1080/14656566.2020.1845649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
52 Khoder G, Muhammad JS, Mahmoud I, Soliman SSM, Burucoa C. Prevalence of Helicobacter pylori and Its Associated Factors among Healthy Asymptomatic Residents in the United Arab Emirates. Pathogens 2019;8:E44. [PMID: 30939800 DOI: 10.3390/pathogens8020044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
53 Ke H, Li J, Lu B, Yang C, Wang J, Wang Z, Liu L, Chen Y. The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth-based quadruple therapy. Helicobacter 2021;26:e12768. [PMID: 33089598 DOI: 10.1111/hel.12768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Tsai CF, Chen MH, Wang YP, Liu PY, Hou MC, Lee FY, Lu CL. Increased risk of short-term depressive disorder after Helicobacter pylori eradication: A population-based nested cohort study. Helicobacter 2021;26:e12824. [PMID: 34117671 DOI: 10.1111/hel.12824] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Kim HW, Woo HJ, Yang JY, Kim JB, Kim SH. Hesperetin Inhibits Expression of Virulence Factors and Growth of Helicobacter pylori. Int J Mol Sci 2021;22:10035. [PMID: 34576198 DOI: 10.3390/ijms221810035] [Reference Citation Analysis]
56 Lu YF, Lyu B. Current situation and prospect of artificial intelligence application in endoscopic diagnosis of Helicobacter pylori infection. Artif Intell Gastrointest Endosc 2021; 2(3): 50-62 [DOI: 10.37126/aige.v2.i3.50] [Reference Citation Analysis]
57 Wang J, Dong F, Su H, Zhu L, Shao S, Wu J, Liu H. H. pylori is related to NAFLD but only in female: A Cross-sectional Study. Int J Med Sci 2021;18:2303-11. [PMID: 33967606 DOI: 10.7150/ijms.50748] [Reference Citation Analysis]
58 Nguyen CT, Davis KA, Nisly SA, Li J. Treatment of Helicobacter pylori in Special Patient Populations. Pharmacotherapy 2019;39:1012-22. [DOI: 10.1002/phar.2318] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
59 Chang SH, Hsieh PL, Tsai GJ. Chitosan Inhibits Helicobacter pylori Growth and Urease Production and Prevents Its Infection of Human Gastric Carcinoma Cells. Mar Drugs 2020;18:E542. [PMID: 33138146 DOI: 10.3390/md18110542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Xie C, Li N, Wang H, He C, Hu Y, Peng C, Ouyang Y, Wang D, Xie Y, Chen J, Shu X, Zhu Y, Lu N. Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to H. pylori infection. Gut Microbes 2020;11:1567-89. [PMID: 32588736 DOI: 10.1080/19490976.2020.1774311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
61 Wu D, Sun Z, Li T, Tan Q, Sun Y, Chen T, Liu Y, Li J, Jiang H, Yuan Z, Zhao Y, Chen W. Efficacy of quadruple regimen with polaprezinc for gastric Helicobacter pylori infection eradication: protocol for a single-centre, single-blind, non-inferiority, randomised clinical trial. BMJ Open 2020;10:e037182. [PMID: 33203625 DOI: 10.1136/bmjopen-2020-037182] [Reference Citation Analysis]
62 Kotilea K, Bontems P, Touati E. Epidemiology, Diagnosis and Risk Factors of Helicobacter pylori Infection. Adv Exp Med Biol. 2019;1149:17-33. [PMID: 31016621 DOI: 10.1007/5584_2019_357] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
63 Xu X, Li W, Qin L, Yang W, Yu G, Wei Q. Relationship between Helicobacter pylori infection and obesity in Chinese adults: A systematic review with meta-analysis. PLoS One 2019;14:e0221076. [PMID: 31509542 DOI: 10.1371/journal.pone.0221076] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
64 Huang Y, Ding Y, Xu H, Shen C, Chen X, Li C. Effects of sodium butyrate supplementation on inflammation, gut microbiota, and short-chain fatty acids in Helicobacter pylori-infected mice. Helicobacter 2021;26:e12785. [PMID: 33609322 DOI: 10.1111/hel.12785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ferro A, Morais S, Pelucchi C, Dierssen-Sotos T, Martín V, López-Carrillo L, Malekzadeh R, Tsugane S, Hamada GS, Hidaka A, Hernández-Ramírez RU, López-Cervantes M, Zaridze D, Maximovitch D, Pourfarzi F, Zhang ZF, Yu GP, Pakseresht M, Ye W, Plymoth A, Leja M, Gasenko E, Derakhshan MH, Negri E, La Vecchia C, Peleteiro B, Lunet N. Sex differences in the prevalence of Helicobacter pylori infection: an individual participant data pooled analysis (StoP Project). Eur J Gastroenterol Hepatol 2019;31:593-8. [PMID: 30839435 DOI: 10.1097/MEG.0000000000001389] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
66 Gunaratne AW, Hamblin H, Clancy A, Magat AJMC, Dawson MVM, Tu J, Borody TJ. Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study. Helicobacter 2021;:e12830. [PMID: 34247436 DOI: 10.1111/hel.12830] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 de Jong JJ, Lantinga MA, Drenth JP. Prevention of overuse: A view on upper gastrointestinal endoscopy. World J Gastroenterol 2019; 25(2): 178-189 [PMID: 30670908 DOI: 10.3748/wjg.v25.i2.178] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
68 Adane H, Atnafie SA, Kifle ZD, Ambikar D. Evaluation of In Vivo Antiulcer Activity of Hydro-Methanol Extract and Solvent Fractions of the Stem Bark of Ficus thonningii (Moraceae) on Rodent Models. Biomed Res Int 2021;2021:6685395. [PMID: 33928161 DOI: 10.1155/2021/6685395] [Reference Citation Analysis]
69 Zhan Y, Si M, Li M, Jiang Y. The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta-analysis. Helicobacter 2019;24:e12562. [PMID: 30672065 DOI: 10.1111/hel.12562] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
70 Haile K, Timerga A. Evaluation of Hematological Parameters of Helicobacter pylori-Infected Adult Patients at Southern Ethiopia: A Comparative Cross-Sectional Study. J Blood Med 2021;12:77-84. [PMID: 33654446 DOI: 10.2147/JBM.S294958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Baj J, Korona-Głowniak I, Forma A, Maani A, Sitarz E, Rahnama-Hezavah M, Radzikowska E, Portincasa P. Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer. Cells 2020;9:E1055. [PMID: 32340207 DOI: 10.3390/cells9041055] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
72 Ibrahim A, Ali YBM, Abdel-Aziz A, El-Badry AA. Helicobacter pylori and enteric parasites co-infection among diarrheic and non-diarrheic Egyptian children: seasonality, estimated risks, and predictive factors. J Parasit Dis 2019;43:198-208. [PMID: 31263324 DOI: 10.1007/s12639-018-1075-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
73 Imawana RA, Smith DR, Goodson ML. The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis. Ann Gastroenterol 2020;33:485-94. [PMID: 32879595 DOI: 10.20524/aog.2020.0507] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Eslick GD, Tilden D, Arora N, Torres M, Clancy RL. Clinical and economic impact of "triple therapy" for Helicobacter pylori eradication on peptic ulcer disease in Australia. Helicobacter 2020;25:e12751. [PMID: 32820568 DOI: 10.1111/hel.12751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Tshibangu-Kabamba E, Phuc BH, Tuan VP, Fauzia KA, Kabongo-Tshibaka A, Kayiba NK, Rosas-Aguirre A, Devleesschauwer B, Cimuanga-Mukanya A, Ngoma Kisoko PJ, Matsumoto T, Akada J, Disashi GT, Mumba Ngoyi D, Kido Y, Speybroeck N, Yamaoka Y. Assessment of the diagnostic accuracy and relevance of a novel ELISA system developed for seroepidemiologic surveys of Helicobacter pylori infection in African settings. PLoS Negl Trop Dis 2021;15:e0009763. [PMID: 34499649 DOI: 10.1371/journal.pntd.0009763] [Reference Citation Analysis]
76 Parkin DM, Hämmerl L, Ferlay J, Kantelhardt EJ. Cancer in Africa 2018: The role of infections. Int J Cancer 2020;146:2089-103. [PMID: 31254479 DOI: 10.1002/ijc.32538] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
77 Marques MS, Melo J, Cavadas B, Mendes N, Pereira L, Carneiro F, Figueiredo C, Leite M. Afadin Downregulation by Helicobacter pylori Induces Epithelial to Mesenchymal Transition in Gastric Cells. Front Microbiol 2018;9:2712. [PMID: 30473688 DOI: 10.3389/fmicb.2018.02712] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
78 Yin JJ, Duan FJ, Madhurapantula SV, Zhang YH, He G, Wang KY, Ji XK, Wang KJ. Helicobacter pylori and gastric cardia cancer: What do we know about their relationship? World J Meta-Anal 2020; 8(2): 89-97 [DOI: 10.13105/wjma.v8.i2.89] [Reference Citation Analysis]
79 Ofori EG, Adinortey CA, Bockarie AS, Kyei F, Tagoe EA, Adinortey MB. Helicobacter pylori Infection, Virulence Genes' Distribution and Accompanying Clinical Outcomes: The West Africa Situation. Biomed Res Int 2019;2019:7312908. [PMID: 31886245 DOI: 10.1155/2019/7312908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Bubić A, Mrnjavac N, Stuparević I, Łyczek M, Wielgus-Kutrowska B, Bzowska A, Luić M, Leščić Ašler I. In the quest for new targets for pathogen eradication: the adenylosuccinate synthetase from the bacterium Helicobacter pylori. J Enzyme Inhib Med Chem 2018;33:1405-14. [PMID: 30191734 DOI: 10.1080/14756366.2018.1506773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Curado MP, de Oliveira MM, de Araújo Fagundes M. Prevalence of Helicobacter pylori infection in Latin America and the Caribbean populations: A systematic review and meta-analysis. Cancer Epidemiol 2019;60:141-8. [PMID: 31009922 DOI: 10.1016/j.canep.2019.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
82 Alvarez D, Wilkinson KA, Treilhou M, Téné N, Castillo D, Sauvain M. Prospecting Peptides Isolated From Black Soldier Fly (Diptera: Stratiomyidae) With Antimicrobial Activity Against Helicobacter pylori (Campylobacterales: Helicobacteraceae). J Insect Sci 2019;19:17. [PMID: 31865367 DOI: 10.1093/jisesa/iez120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
83 Szaflarska-popławska A, Soroczyńska-wrzyszcz A. Prevalence of Helicobacter pylori infection among junior high school students in Grudziadz, Poland. Helicobacter 2019;24:e12552. [DOI: 10.1111/hel.12552] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
84 Kotilea K, Kalach N, Homan M, Bontems P. Helicobacter pylori Infection in Pediatric Patients: Update on Diagnosis and Eradication Strategies. Pediatr Drugs 2018;20:337-51. [DOI: 10.1007/s40272-018-0296-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
85 Park WJ, Kim SH, Kang W, Ahn JS, Cho S, Lim DY, Kim S, Moon JD. Blood lead level and Helicobacter pylori infection in a healthy population: A cross-sectional study. Arch Environ Occup Health 2020;75:333-8. [PMID: 31429670 DOI: 10.1080/19338244.2019.1654969] [Reference Citation Analysis]
86 Ali B, Chloë W, Mehmet A, Sofie B, Annemieke S, Gökhan T, Tülin GG, Freddy H, Fatih K. Presence of gastric Helicobacter species in children suffering from gastric disorders in Southern Turkey. Helicobacter 2018;23:e12511. [PMID: 29974550 DOI: 10.1111/hel.12511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
87 Jaka H, Mueller A, Kasang C, Mshana SE. Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study. BMC Infect Dis 2019;19:447. [PMID: 31113384 DOI: 10.1186/s12879-019-4085-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
88 Gottesmann M, Goycoolea FM, Steinbacher T, Menogni T, Hensel A. Smart drug delivery against Helicobacter pylori: pectin-coated, mucoadhesive liposomes with antiadhesive activity and antibiotic cargo. Appl Microbiol Biotechnol 2020;104:5943-57. [PMID: 32399588 DOI: 10.1007/s00253-020-10647-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
89 Aguilera Matos I, Diaz Oliva SE, Escobedo AA, Villa Jiménez OM, Velazco Villaurrutia YDC. Helicobacter pylori infection in children. BMJ Paediatr Open 2020;4:e000679. [PMID: 32818155 DOI: 10.1136/bmjpo-2020-000679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Epstein TD, Wu B, Moulton KD, Yan M, Dube DH. Sugar-Modified Analogs of Auranofin Are Potent Inhibitors of the Gastric Pathogen Helicobacter pylori. ACS Infect Dis 2019;5:1682-7. [PMID: 31487153 DOI: 10.1021/acsinfecdis.9b00251] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
91 Dargenio C, Dargenio VN, Bizzoco F, Indrio F, Francavilla R, Cristofori F. Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection. Medicina (Kaunas) 2021;57:733. [PMID: 34357014 DOI: 10.3390/medicina57070733] [Reference Citation Analysis]
92 Pritchard DM, Bornschein J, Beales I, Beresniak A, Salhi H, Malfertheiner P. Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK. BMJ Open Gastroenterol 2021;8:e000685. [PMID: 34244244 DOI: 10.1136/bmjgast-2021-000685] [Reference Citation Analysis]
93 Kori M, Le Thi TG, Werkstetter K, Sustmann A, Bontems P, Lopes AI, Oleastro M, Iwanczak B, Kalach N, Misak Z, Cabral J, Homan M, Cilleruelo Pascual ML, Pehlivanoglu E, Casswall T, Urruzuno P, Martinez Gomez MJ, Papadopoulou A, Roma E, Dolinsek J, Rogalidou M, Urbonas V, Chong S, Kindermann A, Miele E, Rea F, Cseh Á, Koletzko S; Helicobacter pylori Working Group of ESPGHAN. Helicobacter pylori Infection in Pediatric Patients Living in Europe: Results of the EuroPedHP Registry 2013 to 2016. J Pediatr Gastroenterol Nutr 2020;71:476-83. [PMID: 32541200 DOI: 10.1097/MPG.0000000000002816] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
94 Tang Y, Yang Y, Lv Z. Adverse pregnancy outcomes and Helicobacter pylori infection: A meta-analysis. Int J Clin Pract 2021;:e14588. [PMID: 34218503 DOI: 10.1111/ijcp.14588] [Reference Citation Analysis]
95 Zhou B, Chen L, Li B, Wan L, Ai Y. Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis with trial sequential analysis. Helicobacter 2019;24. [DOI: 10.1111/hel.12651] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
96 Rezaei S, Talebi Bezmin Abadi A, Mohabatti Mobarez A. Metronidazole-resistant Helicobacter pylori isolates without rdxA mutations obtained from Iranian dyspeptic patients. New Microbes New Infect 2020;34:100636. [PMID: 31993205 DOI: 10.1016/j.nmni.2019.100636] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
97 Suárez-Jaramillo A, Baldeón ME, Prado B, Fornasini M, Cohen H, Flores N, Salvador I, Cargua O, Realpe J, Cárdenas PA. Duodenal microbiome in patients with or without Helicobacter pylori infection. Helicobacter 2020;25:e12753. [PMID: 32896972 DOI: 10.1111/hel.12753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
98 Sabbagh P, Mohammadnia-afrouzi M, Javanian M, Babazadeh A, Koppolu V, Vasigala VR, Nouri HR, Ebrahimpour S. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. Eur J Clin Microbiol Infect Dis 2019;38:55-66. [DOI: 10.1007/s10096-018-3414-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
99 Palacios-Espinosa JF, Núñez-Aragón PN, Gomez-Chang E, Linares E, Bye R, Romero I. Anti-Helicobacter pylori Activity of Artemisia ludoviciana subsp. mexicana and Two of Its Bioactive Components, Estafiatin and Eupatilin. Molecules 2021;26:3654. [PMID: 34203927 DOI: 10.3390/molecules26123654] [Reference Citation Analysis]
100 Rueda-Robles A, Rubio-Tomás T, Plaza-Diaz J, Álvarez-Mercado AI. Impact of Dietary Patterns on H. pylori Infection and the Modulation of Microbiota to Counteract Its Effect. A Narrative Review. Pathogens 2021;10:875. [PMID: 34358024 DOI: 10.3390/pathogens10070875] [Reference Citation Analysis]
101 Uddin R, Khalil W. A comparative proteomic approach using metabolic pathways for the identification of potential drug targets against Helicobacter pylori. Genes Genomics 2020;42:519-41. [PMID: 32193857 DOI: 10.1007/s13258-020-00921-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Tsipotis E, Leontiadis GI. Editorial: the prevalence of Helicobacter pylori infection worldwide-knowns and unknowns. Aliment Pharmacol Ther 2018;47:1330-1. [DOI: 10.1111/apt.14609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
103 Cardos IA, Zaha DC, Sindhu RK, Cavalu S. Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies. Molecules 2021;26:6078. [PMID: 34641620 DOI: 10.3390/molecules26196078] [Reference Citation Analysis]
104 Yu F, Qin S, Wang S, Wang J. Regular arrangement of collecting venules (RAC) as an endoscopic marker for exclusion of Helicobacter pylori (H. pylori) infection: A systematic review and meta-analysis. Int J Clin Pract 2021;:e14548. [PMID: 34137145 DOI: 10.1111/ijcp.14548] [Reference Citation Analysis]
105 Khdair Ahmad F, Aladily TN, Altamimi M, Ajour M, Alsaber N, Rawashdeh M. Helicobacter pylori Prevalence and Impact: A Histology-Based Report About Children from an Endemic Country. Int J Gen Med 2020;13:207-14. [PMID: 32547162 DOI: 10.2147/IJGM.S240205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Liu J, Ji CR, Li YY, Qiao C, Hu JN, Wan M, Lin MJ, Lin BS, Wang J, Zha J, Li LX, Zuo XL. Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot Study. Clin Transl Gastroenterol 2021;12:e00391. [PMID: 34397042 DOI: 10.14309/ctg.0000000000000391] [Reference Citation Analysis]
107 Yang‐ou Y, Hu Y, Zhu Y, Lu N. The effect of antioxidants on Helicobacter pylori eradication: A systematic review with meta‐analysis. Helicobacter 2018;23. [DOI: 10.1111/hel.12535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
108 Afsar MNA, Jhinu ZN, Bhuiyan MAI, Islam Z, Siddiqua TJ. Helicobacter pylori infection and micronutrient deficiency in pregnant women: a systematic review and meta-analysis. BMJ Open Gastroenterol 2020;7:e000490. [PMID: 33093020 DOI: 10.1136/bmjgast-2020-000490] [Reference Citation Analysis]
109 Willems P, de Repentigny J, Hassan GM, Sidani S, Soucy G, Bouin M. The Prevalence of Helicobacter pylori Infection in a Quaternary Hospital in Canada. J Clin Med Res 2020;12:687-92. [PMID: 33224369 DOI: 10.14740/jocmr4348] [Reference Citation Analysis]
110 Zhou W, Kanetaka K, Yoneda A, Kobayashi S, Hidaka M, Eguchi S. The efficacy of intraoperative indocyanine green fluorescence angiography in gastric cancer operation after living donor liver transplantation: A case report. Int J Surg Case Rep 2020;77:614-7. [PMID: 33395858 DOI: 10.1016/j.ijscr.2020.11.090] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Xie W, Zhao W, Zou Z, Kong L, Yang L. Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice. Helicobacter 2021;26. [DOI: 10.1111/hel.12807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Milivojevic V, Milosavljevic T. Burden of Gastroduodenal Diseases from the Global Perspective. Curr Treat Options Gastroenterol 2020. [PMID: 31993967 DOI: 10.1007/s11938-020-00277-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
113 Sharafutdinov I, Backert S, Tegtmeyer N. The Helicobacter pylori type IV secretion system upregulates epithelial cortactin expression by a CagA- and JNK-dependent pathway. Cell Microbiol 2021;:e13376. [PMID: 34197673 DOI: 10.1111/cmi.13376] [Reference Citation Analysis]
114 Yang F, Zhang J, Wang S, Sun Z, Zhou J, Li F, Liu Y, Ding L, Liu Y, Chi W, Liu T, He Y, Xiang P, Bao Z, Olszewski MA, Zhao H, Zhang Y. Genomic population structure of Helicobacter pylori Shanghai isolates and identification of genomic features uniquely linked with pathogenicity. Virulence 2021;12:1258-70. [PMID: 33904371 DOI: 10.1080/21505594.2021.1920762] [Reference Citation Analysis]
115 Bálint L, Tiszai A, Kozák G, Dóczi I, Szekeres V, Inczefi O, Ollé G, Helle K, Róka R, Rosztóczy A. Epidemiologic characteristics of Helicobacter pylori infection in southeast Hungary. World J Gastroenterol 2019; 25(42): 6365-6372 [PMID: 31754296 DOI: 10.3748/wjg.v25.i42.6365] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
116 Maubach G, Sokolova O, Täger C, Naumann M. CEACAMs interaction with Helicobacter pylori HopQ supports the type 4 secretion system-dependent activation of non-canonical NF-κB. Int J Med Microbiol 2020;310:151444. [PMID: 32862837 DOI: 10.1016/j.ijmm.2020.151444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
117 Ansari S, Yamaoka Y. Current understanding and management of Helicobacter pylori infection: an updated appraisal. F1000Res. 2018;7. [PMID: 29946428 DOI: 10.12688/f1000research.14149.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
118 Wu F, Chen C, Peng F. Potential Association Between Asthma, Helicobacter pylori Infection, and Gastric Cancer. Front Oncol 2021;11:630235. [PMID: 33763365 DOI: 10.3389/fonc.2021.630235] [Reference Citation Analysis]
119 Gemilyan M, Hakobyan G, Benejat L, Allushi B, Melik-Nubaryan D, Mangoyan H, Laur A, Daguerre E, Grigoryan E, Megraud F. Prevalence of Helicobacter pylori infection and antibiotic resistance profile in Armenia. Gut Pathog 2019;11:28. [PMID: 31182977 DOI: 10.1186/s13099-019-0310-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
120 Boyanova L, Markovska R, Hadzhiyski P, Kandilarov N, Mitov I. Rifamycin use for treatment of Helicobacter pylori infection: a review of recent data. Future Microbiol 2020;15:1185-96. [PMID: 32954842 DOI: 10.2217/fmb-2020-0084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
121 Keikha M, Ali-Hassanzadeh M, Karbalaei M. Association of Helicobacter pylori vacA genotypes and peptic ulcer in Iranian population: a systematic review and meta-analysis. BMC Gastroenterol 2020;20:266. [PMID: 32795257 DOI: 10.1186/s12876-020-01406-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
122 Jukic I, Rusic D, Vukovic J, Zivkovic PM, Bukic J, Leskur D, Seselja Perisin A, Luksic M, Modun D. Correlation of registered drug packs with Maastricht V/Florence Consensus Report and national treatment guidelines for management of Helicobacter pylori infection. Basic Clin Pharmacol Toxicol 2020;126:212-25. [DOI: 10.1111/bcpt.13322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
123 Henriques PC, Costa LM, Seabra CL, Antunes B, Silva-Carvalho R, Junqueira-Neto S, Maia AF, Oliveira P, Magalhães A, Reis CA, Gartner F, Touati E, Gomes J, Costa P, Martins MCL, Gonçalves IC. Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice. Acta Biomater 2020;114:206-20. [PMID: 32622054 DOI: 10.1016/j.actbio.2020.06.035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
124 Liu J, Yu R, Jia J, Gu W, Zhang H. Assignment of Absolute Configurations of Two Promising Anti-Helicobacter pylori Agents from the Marine Sponge-Derived Fungus Aspergillus niger L14. Molecules 2021;26:5061. [PMID: 34443650 DOI: 10.3390/molecules26165061] [Reference Citation Analysis]
125 Khoder G, Mina S, Mahmoud I, Muhammad JS, Harati R, Burucoa C. Helicobacter pylori Infection in Tripoli, North Lebanon: Assessment and Risk Factors. Biology (Basel) 2021;10:599. [PMID: 34203570 DOI: 10.3390/biology10070599] [Reference Citation Analysis]
126 Li Z, Wang J, Cheng X, Hu H, Guo C, Huang J, Chen Z, Lu J. The worldwide seroprevalence of DENV, CHIKV and ZIKV infection: A systematic review and meta-analysis. PLoS Negl Trop Dis 2021;15:e0009337. [PMID: 33909610 DOI: 10.1371/journal.pntd.0009337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
127 Altamimi E, Alsharkhat N, AlJawarneh A, Abu Hamad MDR, Assi AA, Alawneh S, Al-Ahmad M. Declining prevalence of Helicobacter pylori infection in Jordanian children, report from developing country. Heliyon 2020;6:e04416. [PMID: 32715122 DOI: 10.1016/j.heliyon.2020.e04416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
128 Lu B, Wang J, Li J, Liu L, Chen Y. Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single‐center, open‐label, randomized trial. Helicobacter 2019;24:e12566. [DOI: 10.1111/hel.12566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
129 Doohan D, Fauzia KA, Rathnayake J, Lamawansa MD, Waskito LA, Tuan VP, Dashdorj A, Kabamba ET, Phuc BH, Ansari S, Akada J, Matsumoto T, Uchida T, Matsuhisa T, Yamaoka Y. Pepsinogen and Serum IgG Detection Is a Valuable Diagnostic Method for Helicobacter pylori Infection in a Low-Prevalence Country: A Report from Sri Lanka. Diagnostics (Basel) 2021;11:1364. [PMID: 34441303 DOI: 10.3390/diagnostics11081364] [Reference Citation Analysis]
130 Idris AB, Idris EB, Ataelmanan AE, Mohamed AEA, Osman Arbab BM, Ibrahim EM, Hassan MA. First insights into the molecular basis association between promoter polymorphisms of the IL1B gene and Helicobacter pylori infection in the Sudanese population: computational approach. BMC Microbiol 2021;21:16. [PMID: 33413117 DOI: 10.1186/s12866-020-02072-3] [Reference Citation Analysis]
131 Hu Y, Zhu Y, Lu NH. Recent progress in Helicobacter pylori treatment. Chin Med J (Engl). 2020;133:335-343. [PMID: 31929363 DOI: 10.1097/cm9.0000000000000618] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
132 Deng W, Jin L, Zhuo H, Vasiliou V, Zhang Y. Alcohol consumption and risk of stomach cancer: A meta-analysis. Chem Biol Interact 2021;336:109365. [PMID: 33412155 DOI: 10.1016/j.cbi.2021.109365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Valentin A, Goetz M, Hetzel J, Reinert S, Hoefert S. Routine panendoscopy in oral squamous cell cancer patients: mandatory or facultative? Clin Oral Investig 2021;25:1245-54. [PMID: 32607829 DOI: 10.1007/s00784-020-03429-8] [Reference Citation Analysis]
134 Liang CM, Hsu CH, Chung CH, Chen CY, Wang LY, Hsu SD, Chang PK, Hong ZJ, Chien WC, Hu JM. Risk for Irritable Bowel Syndrome in Patients with Helicobacter Pylori Infection: A Nationwide Population-Based Study Cohort Study in Taiwan. Int J Environ Res Public Health 2020;17:E3737. [PMID: 32466223 DOI: 10.3390/ijerph17103737] [Reference Citation Analysis]
135 de Lima Silva LL, Oliveira AKS, Gama AR, Ramos AFPL, Silva AMTC, Blanco AJV, Vieira JDG, Rasmussem LT, Carneiro LC, Barbosa MS. Helicobacter pylori virulence dupA gene: risk factor or protective factor? Braz J Microbiol 2021. [PMID: 34255308 DOI: 10.1007/s42770-021-00553-9] [Reference Citation Analysis]
136 Zamani M, Alizadeh-Tabari S, Hasanpour AH, Eusebi LH, Ford AC. Systematic review with meta-analysis: association of Helicobacter pylori infection with gastro-oesophageal reflux and its complications. Aliment Pharmacol Ther 2021;54:988-98. [PMID: 34437710 DOI: 10.1111/apt.16585] [Reference Citation Analysis]
137 Kountouras J, Polyzos SA, Doulberis M, Zeglinas C, Artemaki F, Vardaka E, Deretzi G, Giartza-Taxidou E, Tzivras D, Vlachaki E, Kazakos E, Katsinelos P, Mantzoros CS. Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis. Metabolism 2018;87:18-24. [PMID: 29936174 DOI: 10.1016/j.metabol.2018.06.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
138 Seyyedmajidi M, Abbasi L, Seyedmajidi S, Hosseini SA, Ahmadi A, Hajiebrahimi S, Vafaeimanesh J. Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori. Caspian J Intern Med 2019;10:211-6. [PMID: 31363400 DOI: 10.22088/cjim.10.2.211] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Agin M, Batun I, Ozdemir S, Doran F, Tumgor G. Prevalence of Helicobacter pylori in Turkish children with celiac disease and its effect on clinical, histopathological, and laboratory parameters. Arch Med Sci 2019;15:1475-81. [PMID: 31749876 DOI: 10.5114/aoms.2019.83699] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
140 Lee Y, Lee SM, Choi J, Kang S, So S, Kim D, Ahn JY, Jung HY, Jeong JY, Kang E. Mitochondrial DNA Haplogroup Related to the Prevalence of Helicobacter pylori. Cells 2021;10:2482. [PMID: 34572132 DOI: 10.3390/cells10092482] [Reference Citation Analysis]
141 Lehours P. Actual diagnosis of Helicobacter pylori infection. Minerva Gastroenterol Dietol 2018;64. [DOI: 10.23736/s1121-421x.18.02494-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
142 Chey WD. Helicobacter pylori: When We Should Treat…. Am J Gastroenterol 2019;114:1829-32. [DOI: 10.14309/ajg.0000000000000425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Wu Y, Su T, Zhou X, Lu N, Li Z, Du Y. Awareness and attitudes regarding Helicobacter pylori infection in Chinese physicians and public population: A national cross-sectional survey. Helicobacter 2020;25:e12705. [PMID: 32476197 DOI: 10.1111/hel.12705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Alizadeh-Naini M, Yousefnejad H, Hejazi N. The beneficial health effects of Nigella sativa on Helicobacter pylori eradication, dyspepsia symptoms, and quality of life in infected patients: A pilot study. Phytother Res 2020;34:1367-76. [PMID: 31916648 DOI: 10.1002/ptr.6610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
145 Andreev DN, Maev IV. [Rebamipide: evidence base for use in gastroenterology]. Ter Arkh 2020;92:97-104. [PMID: 33720581 DOI: 10.26442/00403660.2020.12.200455] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
146 Han Y, Yan T, Ma H, Yao X, Lu C, Li Y, Li L. Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model. Dig Dis Sci. 2020;65:1679-1688. [PMID: 31673902 DOI: 10.1007/s10620-019-05910-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
147 Maluf S, Salgado JV, Cysne DN, Camelo DMF, Nascimento JR, Maluf BVT, Silva LDM, Belfort MRC, Silva LA, Guerra RNM, Salgado Filho N, Nascimento FRF. Increased Glycated Hemoglobin Levels in Patients With Helicobacter pylori Infection Are Associated With the Grading of Chronic Gastritis. Front Immunol 2020;11:2121. [PMID: 33013895 DOI: 10.3389/fimmu.2020.02121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Zhang Q, Wu W, Zhang J, Xia X. Eradication of Helicobacter pylori: the power of nanosized formulations. Nanomedicine (Lond) 2020;15:527-42. [PMID: 32028847 DOI: 10.2217/nnm-2019-0329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
149 Xu C, Soyfoo DM, Wu Y, Xu S. Virulence of Helicobacter pylori outer membrane proteins: an updated review. Eur J Clin Microbiol Infect Dis 2020;39:1821-30. [PMID: 32557327 DOI: 10.1007/s10096-020-03948-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
150 Tsang SH, Avilés-Santa ML, Abnet CC, Brito MO, Daviglus ML, Wassertheil-Smoller S, Castañeda SF, Minnerath S, Talavera GA, Graubard BI, Thyagarajan B, Camargo MC. Seroprevalence and Determinants of Helicobacter pylori Infection in the Hispanic Community Health Study/Study of Latinos. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00221-4. [PMID: 33667677 DOI: 10.1016/j.cgh.2021.02.042] [Reference Citation Analysis]
151 Miernyk KM, Bruden D, Rudolph KM, Hurlburt DA, Sacco F, McMahon BJ, Bruce MG. Presence of cagPAI genes and characterization of vacA s, i and m regions in Helicobacter pylori isolated from Alaskans and their association with clinical pathologies. J Med Microbiol 2020;69:218-27. [PMID: 32011229 DOI: 10.1099/jmm.0.001123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Fong P, Wang QT. Protective effect of oral contraceptive against Helicobacter pylori infection in US adult females: NHANES 1999-2000. Epidemiol Infect 2021;149:e120. [PMID: 33896437 DOI: 10.1017/S0950268821000923] [Reference Citation Analysis]
153 Lucio-Sauceda DG, Urrutia-Baca VH, Gomez-Flores R, De La Garza-Ramos MA, Tamez-Guerra P, Orozco-Flores A. Antimicrobial and Anti-Biofilm Effect of an Electrolyzed Superoxidized Solution at Neutral-pH against Helicobacter pylori. Biomed Res Int 2019;2019:6154867. [PMID: 31930132 DOI: 10.1155/2019/6154867] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Shu X, Cai H, Lan Q, Cai Q, Ji BT, Zheng W, Shu XO. A Prospective Investigation of Circulating Metabolome Identifies Potential Biomarkers for Gastric Cancer Risk. Cancer Epidemiol Biomarkers Prev 2021;30:1634-42. [PMID: 33795214 DOI: 10.1158/1055-9965.EPI-20-1633] [Reference Citation Analysis]
155 Wang D, Li Y, Zhong H, Ding Q, Lin Y, Tang S, Zong Y, Wang Q, Zhang X, Yang H, Wang R, Liu X. Alterations in the human gut microbiome associated with Helicobacter pylori infection. FEBS Open Bio 2019;9:1552-60. [PMID: 31250988 DOI: 10.1002/2211-5463.12694] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
156 Khani S, Talebi Bezmin Abadi A, Mohabati Mobarez A. Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients' Stomachs. Infect Drug Resist 2019;12:3415-20. [PMID: 31802920 DOI: 10.2147/IDR.S223602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Heydari S, Siavoshi F, Jazayeri MH, Sarrafnejad A, Saniee P. Helicobacter pylori release from yeast as a vesicle-encased or free bacterium. Helicobacter 2020;25:e12725. [PMID: 32666589 DOI: 10.1111/hel.12725] [Reference Citation Analysis]
158 Kori M, Daugule I, Urbonas V. Helicobacter pylori and some aspects of gut microbiota in children. Helicobacter. 2018;23 Suppl 1:e12524. [PMID: 30203591 DOI: 10.1111/hel.12524] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
159 Obaidat MM, Roess AA. First nationwide seroepidemiology and risk factors report of Helicobater pylori in Jordan. Helicobacter 2019;24:e12572. [PMID: 30868689 DOI: 10.1111/hel.12572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Gao T, Hou M, Zhang B, Pan X, Liu C, Sun C, Jia M, Lin S, Xiong K, Ma A. Effects of cranberry beverages on oxidative stress and gut microbiota in subjects with Helicobacter pylori infection: a randomized, double-blind, placebo-controlled trial. Food Funct 2021;12:6878-88. [PMID: 34126630 DOI: 10.1039/d1fo00467k] [Reference Citation Analysis]
161 Panebianco C, Pazienza V. Body site-dependent variations of microbiota in pancreatic cancer pathophysiology. Crit Rev Clin Lab Sci 2019;56:260-73. [PMID: 31060399 DOI: 10.1080/10408363.2019.1615407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
162 Sjomina O, Pavlova J, Niv Y, Leja M. Epidemiology of Helicobacter pylori infection. Helicobacter. 2018;23 Suppl 1:e12514. [PMID: 30203587 DOI: 10.1111/hel.12514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 23.5] [Reference Citation Analysis]
163 Westerik N, Reid G, Sybesma W, Kort R. The Probiotic Lactobacillus rhamnosus for Alleviation of Helicobacter pylori-Associated Gastric Pathology in East Africa. Front Microbiol 2018;9:1873. [PMID: 30154777 DOI: 10.3389/fmicb.2018.01873] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
164 Capitani N, Codolo G, Vallese F, Minervini G, Grassi A, Cianchi F, Troilo A, Fischer W, Zanotti G, Baldari CT, de Bernard M, D'Elios MM. The lipoprotein HP1454 of Helicobacter pylori regulates T-cell response by shaping T-cell receptor signalling. Cell Microbiol 2019;21:e13006. [PMID: 30646431 DOI: 10.1111/cmi.13006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
165 Walduck AK, Raghavan S. Immunity and Vaccine Development Against Helicobacter pylori. Adv Exp Med Biol 2019;1149:257-75. [PMID: 31016627 DOI: 10.1007/5584_2019_370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
166 He Y, Wang C, Zhang X, Lu X, Xing J, Lv J, Guo M, Huo X, Liu X, Lu J, Du X, Li C, Chen Z. Sustained Exposure to Helicobacter pylori Lysate Inhibits Apoptosis and Autophagy of Gastric Epithelial Cells. Front Oncol 2020;10:581364. [PMID: 33194715 DOI: 10.3389/fonc.2020.581364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
167 Haile K, Yemane T, Tesfaye G, Wolde D, Timerga A, Haile A. Anemia and its association with Helicobacter pylori infection among adult dyspeptic patients attending Wachemo University Nigist Eleni Mohammad Memorial Referral Hospital, Southwest Ethiopia: A cross-sectional study. PLoS One 2021;16:e0245168. [PMID: 33444345 DOI: 10.1371/journal.pone.0245168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Peng X, Zhang R, Duan G, Wang C, Sun N, Zhang L, Chen S, Fan Q, Xi Y. Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity. Sci Rep 2018;8:6435. [PMID: 29691472 DOI: 10.1038/s41598-018-24879-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]